Propionibacterium acnes Susceptibility and Correlation with Hemolytic Phenotype
Travis E Wright, K Keely Boyle, Thomas R Duquin, John K Crane, Travis E Wright, K Keely Boyle, Thomas R Duquin, John K Crane
Abstract
Background: Many studies have noted an increase in the number of recognized cases of invasive infections due to Propionibacterium acnes, especially after shoulder replacement surgery. The increase in the number of recognized cases of P. acnes, a nonspore-forming, anaerobic, Gram-positive organism, appears due to both an increase in the number of shoulder operations being performed and more specimens being sent for anaerobic cultures. Nevertheless, the optimal surgical and antibiotic management of P. acnes remains controversial.
Methods: We tested the susceptibility of 106 P. acnes strains from sterile body sites collected at the Erie County Medical Center between 2012 and 2015, using Etest gradient antibiotic strips.
Results: P. acnes is very susceptible to the penicillins and the first-generation cephalosporins. We noted an association between hemolytic phenotype on Brucella Blood Agar and clindamycin resistance.
Conclusions: Antimicrobial susceptibility testing of P. acnes should no longer just be confined to the research laboratory but expanded and incorporated into routine microbiological evaluation of P. acnes. This would improve patient care as well as help clarify the relationship between hemolysis and clindamycin resistance.
Keywords: clindamycin; hemolysin; penicillin G; sarcoidosis.
Conflict of interest statement
TRD discloses a research grant and consulting fees from Zimmer-Biomet, outside the work presented here. Other authors disclose no potential conflicts of interest.
Figures
References
- Crane JK, Hohman DW, Nodzo SR, Duquin TR. Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery. Antimicrob Agents Chemother. 2013;57:3424–3426.
- Levy PY, Fenollar F, Stein A, et al. Propionibacterium acnes postoperative shoulder arthritis: an emerging clinical entity. Clin Infect Dis. 2008;46:1884–1886.
- Wang B, Toye B, Desjardins M, Lapner P, Lee C. A 7-year retrospective review from 2005 to 2011 of Propionibacterium acnes shoulder infections in Ottawa, Ontario, Canada. Diag Microbiol Infect Dis. 2013;75:195–199.
- Aubin GG, Portillo ME, Trampuz A, Corvec S. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance. Médecine et Maladies Infectieuses. 2014;44:241–250.
- Fujii Y, Nomuar T, Yokoyama R, Shinoda S, Okamoto K. Studies on the mechanism of action of the aerolysin-like hemolysin of Aeromonas sobria in stimulating T84 cells to produce cyclic AMP. Infect Immun. 2003;71:1557–1560.
- Ichikawa H, Kataoka M, Hiramatsu J, et al. Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasculitis Diffuse Lung Dis. 2008;25:15–20.
- Gonzalez R, Welsh O, Ocampo J, et al. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico. Int J Dermatol. 2010;49:1003–1007.
- Oprica C, Nord CE, ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect. 2005;11:204–213.
- Song M, Seo S-H, Ko H-C, et al. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. J Dermatol. 2011;38:667–673.
- Nodzo S, Hohman D, Crane J, Duquin T. Hemolysis as a clinical marker for Propionibacterium acnes orthopedic infection. Am J Orthop. 2014;43:E93–E97.
- Perry AL, Worthington T, Hilton AC, Lambert PA, Stirling AJ, Elliott TSJ. Analysis of clinical isolates of Propionibacterium acnes by optimised RAPD. FEMS Microbiol Lett. 2003;228:51–55.
- Cercenado E, Eliopoulos GM, Wennersten CB, Moellering RC. Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin. Antimicrob Agents Chemother. 1992;36:2526–2528.
- Shah NB, Tande AJ, Patel R, Berbari EF. Anaerobic prosthetic joint infection. Anaerobe. 2015;36:1–8.
- Brüggemann H, Henne A, Hoster F, et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science. 2004;305:671–673.
- El-Mahdy TS, Abdalla S, El-Domany R, Mohamed MS, Ross JI, Snelling AM. Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria. Anaerobe. 2010;16:376–379. .
- Bayston R, Ashraf W, Jacobs A, Goosen J. Treatment of Prosthetic Joint Infections Due to Propionibacterium. Vol. 87. Oxon, England: Taylor & Francis Ltd; 2016. pp. 318–319.
- Corvec S, Aubin GG, Bayston R, Ashraf W. Which is the best treatment for prosthetic joint infections due to Propionibacterium acnes: need for further biofilm in vitro and experimental foreign-body in vivo studies? Acta Orthop. 2016;87:318–319.
- Jacobs AME, Van Hooff ML, Meis JF, Vos F, Goosen JHM. Treatment of prosthetic joint infections due to Propionibacterium. Acta Orthop. 2016;87:60–66.
- Furustrand Tafin U, Corvec S, Betrisey B, Zimmerli W, Trampuz A. Role of Rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2012;56:1885–1891.
Source: PubMed